OncoZenge AB (publ) (STO:ONCOZ)
Sweden · Delayed Price · Currency is SEK 3.600
-0.050 (-1.37%)
Oct 14, 2026, 5:29 PM CET
OncoZenge AB Market Cap
OncoZenge AB has a market cap or net worth of 99.36 million as of October 14, 2026. It is the 41,609th most valuable company in the world and the 604th biggest in Sweden. Its market cap has increased by 42.85% in one year.
Market Cap
99.36M
Enterprise Value
106.12M
Revenue
5.97M
Global Rank
Country Rank
#604 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since February 12, 2021, OncoZenge AB's market cap has increased from 89.02M to 99.36M, an increase of 11.62%. That is a compound annual growth rate of 1.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 99.36M | 16.22% |
| Dec 30, 2025 | 85.49M | 94.64% |
| Dec 30, 2024 | 43.92M | 21.36% |
| Dec 29, 2023 | 36.19M | -43.82% |
| Dec 30, 2022 | 64.42M | -52.42% |
| Dec 30, 2021 | 135.41M | 52.11% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alzinova AB | 148.52M |
| Abera Bioscience AB | 140.62M |
| Initiator Pharma | 136.56M |
| NextCell Pharma AB | 121.72M |
| Active Biotech AB | 91.08M |
| Ascelia Pharma AB | 90.80M |
| Spago Nanomedical AB | 87.42M |
| Biovica International AB | 86.99M |